Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT01783210 |
Other study ID # |
4043/CE |
Secondary ID |
|
Status |
Recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
July 2012 |
Est. completion date |
June 1, 2022 |
Study information
Verified date |
October 2021 |
Source |
University of Modena and Reggio Emilia |
Contact |
Fabio F Facchinetti, MD |
Phone |
0039 059 4222512 |
Email |
facchi[@]unimore.it |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The investigators evaluate if changing eating habits and introducing a correct lifestyle in
women with BMI >25 Kg/m2 would improve unfavorable maternal-fetal outcomes associated with
excessive weight gain (EWG) during pregnancy. To pursue these goals, eligible women are
randomly assigned to no intervention (Control group) that receive only a simple nutritional
booklet about lifestyle and healthy diet during pregnancy without explicit caloric
restriction or the Therapeutic Lifestyle Changes Program (TLC group) that receive a caloric
restriction (1500 Kcal/day divided in3 main meals and 3 snacks + 300 kcal/die for overweight
or 200 kcal/die for obese women submitted to energy expenditure program) associated to a mild
physical activity (30 minutes at least 3 days/week) The investigators use a tool that could
easily and practically evaluate not only total GWG at term, but also changes in maternal body
composition: the bioimpedance analyzer.
Description:
Pregnant women, recruited from antenatal clinics, with pre-pregnancy BMI ≥ 25 kg/m2, age >18
years and single pregnancy are enrolled within 12th week at the Obstetric Unit of Policlinico
Hospital of Modena.
Exclusion criteria are as follows: twin pregnancies, chronic diseases (i.e., diabetes
mellitus, chronic hypertension, untreated thyroid diseases), gestational diabetes mellitus
(GDM) in previous pregnancies, smoking during pregnancy, dietary supplements or herbal
products known to affect body weight, other medical conditions that might affect body weight,
and plans to deliver outside of the Birth Center.
At the first visit, an accurate obstetric history, family history, and personal history is
collected for the assessment of exclusion criteria. The blood pressure, height and weight are
measured, and the BMI is calculated.
Eligible women are randomly assigned to no intervention (Control group) or the Therapeutic
Lifestyle Changes Program (TLC group). Randomization is performed using sealed
envelopes(using a computer-generated random allocation). Study randomization is numbered and
sealed in white envelops. Randomization occurs in consecutive order at time of the first
visit. Due to study design, both gynecologist and dietitian know the allocation of the
patient.
Every subject receives care in another institution (Antenatal Clinics of Modena Health
program). Hence, women in both groups receive the same antenatal evaluation including two
ultrasound examinations and at least 4 obstetric evaluations until term. However, referral
gynecologists possibly know the allocated arm of their women.
Randomized subjects receive a 75-g 2-h Oral Glucose Tolerance Test (OGTT) at 16-18 and/or
24-28 weeks. The diagnosis of GDM is made for any glucose value exceeding the normal cut-off,
as reported by the HAPO study. If OGTT is pathological, women are referred to other health
care specialists.
Women randomized to both group are scheduled to have a specific follow-up for adherence to
the program at 16, 20, 28, 36 weeks and 3 months after delivery also evaluating the fat mass,
fat-free mass and total body water through the use of the bioimpedance analyzer. At baseline
and 36 weeks each subject have to complete a Food Frequency Questionnaire (FFQ) to identify
any change in eating habits. The FFQ includes questions about specific food items, such as
the frequency of sauce consumption, the fat content of several food items, and seasonal
consumption of fruit and vegetables. While the Control group receives only a simple
nutritional booklet about a lifestyle (in accordance with Italian Guidelines for a healthy
diet during pregnancy), the TLC Program includes a specific caloric restriction associated to
a mild physical activity program.
The TLC diet comprises 1500 kcal/day and consists of 3 main meals and 3 snacks (breakfast,
snack, lunch, snack, dinner, and evening snack) that corresponds to the baseline metabolism
of a pregnant woman. The dietitian adds an amount of 200 kcal/day for obese or 300 kcal/day
for overweight pregnant women submitted to physical activity program.The TLC diet has a
target macronutrient composition of 55% carbohydrate, 20% protein, and 25% fat with
moderately low saturated fat levels. The exercise intervention is focused on increasing
walking and developing a more active lifestyle (i.e., walking rather than driving for short
distances). The recommended exercise prescription for pregnant women is generally consistent
with recommendations for the general adult population. However, it is important to monitor
and adjust exercise prescriptions according to the woman's symptoms, discomforts, and
abilities during pregnancy and be aware of contraindications for exercising during pregnancy.
All participants are advised to participate in 30 min of moderate intensity activity at least
3 days a week. Subjects wear a pedometer (Omron Walking Style III HJ-203-EK) on a belt at the
back of their waist during walking session for the assessment of the adherence to the
physical activity program.